methyl 2-(2-methylphenyl)-2-oxoacetate

We are methyl 2-(2-methylphenyl)-2-oxoacetate CAS:34966-54-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:methyl 2-(2-methylphenyl)-2-oxoacetate
CAS.NO:34966-54-6
Synonyms:methyl 2-(2-methylphenyl)-2-oxoacetate
METHYL 2-METHYLBENZOYLFORMATE
(2-methylphenyl)-glyoxylic acid methyl ester
methyl (2-methylphenyl)glyoxylate
2-oxo-2-(o-tolyl)acetic acid methyl ester
Methyl 2-oxo-2-(o-tolyl)acetate
methyl o-methyl phenyl glyoxylate
 
Physical and Chemical Properties:
Density 1.133
Boiling Point 274ºC
Molecular Formula C10H11O3
Molecular Weight 179.19300
Flash Point 120℃
Index of Refraction 1.516
 
Specification:
Appearance:Yellow oily liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Kresoxim-methyl(CAS:143390-89-0).

methyl 2-(2-methylphenyl)-2-oxoacetate


Related News: Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.3-bromo-1-phenyl-5-pyridin-2-ylpyridin-2-one CAS:381248-06-2 U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.2-Fluorobenzylamine In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.3-Amino-5-bromo-2-chloropyridine CAS:588729-99-1 At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.

Related Products
Product Name
Moxifloxacin Hydrochloride Cas:186826-86-8 View Details
1-Phenyl-5-pyrazolone-3-carboxylic Acid View Details
1-Dimethylamino-2-propanol Cas:108-16-7 View Details
PALLADIUM(II) IODIDE Cas:7790-38-7 manufacturer ANTIOXIDANT 1425 Cas:65140-91-2 manufacturer chlorosulfonyl isocyanate Cas:1189-71-5 manufacturer Sitagliptin Phosphate Monohydrate Cas:654671-77-9 manufacturer N-BUTYLTRIMETHOXYSILANE manufacturer